SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake
Cancer Letters · 2023
DOI: 10.1016/j.canlet.2023.216412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Peng Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Eighth Affliated Hospital, Sun Yat-sen University, No. 3025 Shennan Zhong Road, Shenzhen, Guangdong, 518033, China. Hauptthemen laut MEDLINE: Osteosarcoma, Arginine, Sp1 Transcription Factor, Bone Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
The function of signal regulatory protein alpha (SIRPA) has been well studied in macrophages and dendritic cells, but relatively less in tumors. Notably, SIRPA is upregulated in osteosarcoma tissues, particularly in metastatic tissues, and is associated with unfavorable clinical outcomes. Knockdown of SIRPA impaired OS cell migration by decreasing specificity protein 1 (SP1) stability and arginine uptake. Importantly, SIRPA phosphorylated SP1 at threonine 278 (Thr278) through extracellular signal-regulated kinase (ERK) activation to protect SP1 from proteasomal degradation. In addition, SP1 increased solute carrier family 7 member 3 (SLC7A3) expression by binding to the SLC7A3 promoter and increased the capability of arginine uptake, thereby facilitating OS cell migration. More interestingly, arginine promoted the stability of SP1 in an ERK-independent manner and thus formed the "SP1 stabilization circle". Combined treatment with the anti-SIRPA antibody and arginase, which blocked the circle, impaired tumor metastasis in mice bearing xenografts formed from SIRPA-overexpressing cells. In summary, our study demonstrates that the upregulation of SIRPA promotes OS metastasis via the "SP1 stabilization circle" and SLC7A3-mediated arginine uptake, which might serve as a target for OS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Eighth Affliated Hospital, Sun Yat-sen University, No. 3025 Shennan Zhong Road, Shenzhen, Guangdong, 518033, China.
- Center for Biotherapy, The Eighth Affliated Hospital, Sun Yat-sen University, No. 3025 Shennan Zhong Road, Shenzhen, Guangdong, 518033, China.
- Department of Orthopedics, The Eighth Affliated Hospital, Sun Yat-sen University, No. 3025 Shennan Zhong Road, Shenzhen, Guangdong, 518033, China. Electronic address: mamj8@mail.sysu.edu.cn.
- Department of Orthopedics, The Eighth Affliated Hospital, Sun Yat-sen University, No. 3025 Shennan Zhong Road, Shenzhen, Guangdong, 518033, China. Electronic address: shenhuiy@mail.sysu.edu.cn.
Zitieren
APA
Wang, P., Song, Y., Li, H., Zhuang, J., Shen, X., Yang, W., Mi, R., Lu, Y., Yang, B., Ma, M., & Shen, H. (2023). SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216412
Vancouver
Wang P, Song Y, Li H, Zhuang J, Shen X, Yang W, et al. SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216412
BibTeX
@article{Wang2023,
author = {Wang, Peng and Song, Yihui and Li, Hongyu and Zhuang, Jiahao and Shen, Xin and Yang, Wen and Mi, Rujia and Lu, Yixuan and Yang, Biao and Ma, Mengjun and Shen, Huiyong},
title = {SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake},
journal = {Cancer Letters},
year = {2023},
doi = {10.1016/j.canlet.2023.216412}
}
EUVIMED